ATHN 7

Safety and Effectiveness of Emicizumab in People With Haemophilia A Enrolled in the ATHN 7 Haemophilia Natural History Study

Author(s):

Tyler W. Buckner, Shannon L. Carpenter, Nabil Daoud, Christine L. Kempton, Lucy Lee, Lynn Malec, Thomas W. McLean, Paul Morton, Carrie O’Neill, Janice M. Staber, Michael Wang, Stacy E. Croteau, Michael Recht
Publication:
Haemophilia
Date:
November 11, 2025
Topics:
Haemophilia

Emicizumab and females with Hemophilia A in the ATHNdataset and prospective ATHN 7 Study

Author(s):

Tammuella Chrisentery-Singleton, Lucy Lee, Paul Morton, Michael Recht
Publication:
ISTH Congress 2024
Date:
June 22-26, 2024
Topics:
emicizumab, hemophilia A, females with hemophilia A, ATHNdataset, ATHN 7

Long-Term Safety and Effectiveness of Emicizumab in People with Hemophilia A in the Hemophilia Natural History Study (ATHN 7)

Author(s):

Michael Recht, Shannon Carpenter, Lucy Lee, Thomas McLean, Paul Morton, Janice Staber, Michael Wang, Tammuella Chrisentery-Singleton
Publication:
ISTH Congress 2024
Date:
June 22-26, 2024
Topics:
emicizumab, hemophilia A, ATHN 7

Quality of Life in Emicizumab-treated People with Hemophilia A in the ATHN 7 Hemophilia Natural History Study – An Assessment of Baseline PROMIS®-29 Scores

Author(s):

Tyler W Buckner, Nabil Daoud, Lucy Lee, Jonathan Schwartz, Karina Raimundo, Michael Recht
Publication:
Blood
Date:
November 28, 2023
Topics:
hemophilia A, emicizumab, ATHN 7

Emicizumab prophylaxis in people with hemophilia A aged ≥50 years with comorbidities: experience from the ATHN 7 hemophilia natural history study

Author(s):

Tyler Buckner, Mike Recht, Lucy Lee, Paul Morton, Nabil Daoud
Publication:
ISTH 2023 Congress (poster)
Date:
June 24-28, 2023
Topics:
Hemophilia, comorbidities

Surgeries and procedures in people with haemophilia A on emicizumab prophylaxis, ATHN 7

Author(s):

Tyler Buckner, Shannon Carpenter, Nabil Daoud, Lucy Lee, Thomas McLean, Paul Morton, Michael Recht
Publication:
European Association for Haemophilia and Allied Disorders (EAHAD) Annual Meeting 2023
Date:
February 7-10, 2023
Topics:
Hemophilia, Treatments, Safety

Designing ATHN 7: Safety, effectiveness and practice of treatment of people with haemophilia in the United States through a natural history cohort study

Author(s):

Tyler W Buckner, Nabil Daoud, Moses Miles, Carrie O’Neill, Crystal Watson, Michael Recht
Publication:
The Journal of Haemophilia Practice
Date:
January 2, 2023
Topics:
ATHN 7, hemophilia treatment

Emicizumab and Females with Hemophilia A: Case Series from ATHN 7

Author(s):

Michael Recht, Nabil Daoud, Lucy Lee, Paul Morton, Leslie J Raffini
Publication:
Blood
Date:
November 15, 2022
Topics:
Emicizumab, females with hemophilia

Safety and Efficacy of Emicizumab in People with Hemophilia A Enrolled in the Hemophilia Natural History Study (ATHN 7)

Author(s):

Tyler Buckner, Shannon Carpenter, Christine Kempton, Lucy Lee, Lynn Malec, Thomas McLean, Paul Morton, Janice Staber, Michael Wang, Michael Recht
Publication:
ISTH 2022 Congress
Date:
July 9-13, 2022
Topics:
Safety, Efficacy, Emicizumab

Hemophilia Natural History Study (ATHN 7): Safety of Current Therapies for People with Hemophilia A or B

Author(s):

Tyler Buckner, Shannon L Carpenter, Nabil Daoud, Nikki Hirsh, Thomas W McLean, Carrie O’Neill, Leslie J Raffini, Ayesha Zia, Michael Recht
Publication:
Blood
Date:
November 5, 2021
Topics:
monitor, safety, new therapies, hemophilia A or B

Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia A and B

Author(s):

Tyler W Buckner, Shannon L Carpenter, Stacy E Croteau, Adam Cuker, Nabil Daoud, Christine L Kempton, Lynn M Malec, Thomas W McLean, Leslie Raffini, Janice M Staber, Michael Wang, Crystal Watson, Ayesha Zia, Michael Recht
Publication:
Blood
Date:
November 5, 2020
Topics:
new therapy, monitoring, HTCs

ATHN 7: A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment for People with Hemophilia – Demographics and Preliminary Results

Author(s):

Tyler W Buckner, Nabdil Daoud, Stacy Croteau, Christine Kempton, Lynn Malec, Janice Staber, Michael Wang, Crystal Watson, Michael Recht
Publication:
ISTH 2020 Virtual Congress
Date:
July 12-14, 2020
Topics:
Safety, Cohort-Study, Hemophilia Therapies

Deaths Associated with Emicizumab in Patients with Hemophilia A

Author(s):

Louis M Aledort
Publication:
New England Journal of Medicine
Date:
February 20, 2020
Topics:
Death, Hemophilia, Emicizumab

Can’t find what you’re looking for?
Please contact support@athn.org for assistance.